:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCarawayTx_rgb_large1.png)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FEyeBio-Logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2FICGLOGO.jpg)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCarawayTx_rgb_large1.png)
21 November 2023Portfolio NewsDementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck- 21 November 2023Portfolio NewsMerck to Acquire Caraway Therapeutics, Inc.
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FTransposon-logo.png)
14 November 2023Portfolio NewsTransposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FEyeBio-Logo.png)
14 November 2023Portfolio NewsEyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCerevance.jpg)
13 November 2023Portfolio NewsCerevance Doses First Patient in ASCEND Phase 2 Clinical Study of CVN424, a First-in-Class, Non-Dopaminergic Therapy for the Treatment of Parkinson’s Disease
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FImbria_Logo_Colour.png)
12 November 2023Portfolio NewsImbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Patients with Cardiac Ischemia and Chronic Stable Angina
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FICGLOGO.jpg)
8 November 2023SV NewsSV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group- 7 November 2023Portfolio NewsImbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Patients with Non-obstructive Hypertrophic Cardiomyopathy
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAVDO_2021logo_color.png)
6 November 2023Portfolio NewsAviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fperfuze-Logo-1.png)
2 November 2023Portfolio NewsPerfuze Announces First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial for the Millipede System
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FVibrato_2023-11-10-182100_isko.png)
1 November 2023Portfolio NewsVibrato Medical Announces Positive Results for Early Feasibility Study of Wearable, Non-Invasive Therapeutic Ultrasound to Treat Chronic Limb-Threatening Ischemia- 1 November 2023Portfolio NewsSitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases
